Prof. Gil Bar-Sela serves as the head of the Cancer center in Emek Medical center, Afula, Israel. Until 2018 he served as the Deputy Director of the Division of Oncology at RHCC, head of the Palliative and Supportive Oncology Unit, and head of the Service for Melanoma and Sarcoma patients. He is currently the elected secretary of the Israeli Association for Clinical Oncology and Radiation Therapy (ISCORT) and also the Chairman of the clinical Board of Oncology, Ruth and Bruce Rappoprt Faculty of Medicine, Technion Israel Institute of Technology.
Professor Gil Bar-Sela is a graduate of the Faculty of Medicine at Ben-Gurion University in Beer-Sheva, Israel. He obtained his Oncology training at Rambam Health Care Campus [RHCC] in Haifa, Israel. In 2003, he received Board certification in Medical and Radiation Oncology. During 2005-06 he worked in research at the Radiation Oncology Branch of the National Cancer Institute in Bethesda USA. In 2013, he received board certification in Palliative medicine- as one of the founders in this area in Israel. He is currently a Clinical Associated Professor at the Bruce Rapapport Faculty of Medicine of Technion, Haifa.
His main Research Interests are: Palliative and supportive care in oncology, Complementary/integrated medicine in oncology, Basic and clinical research of chemotherapy side effects and the clinical area of Sarcoma and Melanoma. In those research areas he published, until 2018 over 130 papers in medical journals and books.
